Clinical Trials on Lewy Body Parkinsonism in Denmark
Total 329 results
-
Novartis PharmaceuticalsCompletedSporadic Inclusion Body MyositisUnited States, Belgium, Italy, Australia, Netherlands, Switzerland, France, United Kingdom, Denmark, Japan
-
Gelesis, Inc.CompletedOverweight and ObesityUnited States, Czechia, Denmark, Italy, Spain
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedMetabolic Diseases | Obesity | Nutrition Disorders | Overweight | Nutritional and Metabolic DiseasesUnited Kingdom, Germany, Belgium, Netherlands, Finland, Sweden, Denmark
-
University of AarhusCompletedOut of Hospital Cardiac ArrestBelgium, Denmark, Estonia, Finland, Germany, Norway
-
Merck Sharp & Dohme LLCCompletedNeuromuscular BlockadeUnited States, Austria, Belgium, Denmark, Germany
-
Theravance BiopharmaTerminatedParkinson's Disease (PD) | MSA | Symptomatic Neurogenic Orthostatic Hypotension | Pure Autonomic Failure (PAF)United States, Spain, United Kingdom, Canada, France, Estonia, Australia, Israel, Denmark, Italy, Poland, New Zealand, Germany, Ukraine, Austria, Bulgaria, Portugal, Hungary, Russian Federation
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderSpain, Denmark, Sweden, Belgium, Finland, Netherlands, United Kingdom, Czechia
-
Boehringer IngelheimCompletedObesity | Insulin ResistanceItaly, United States, Canada, Germany, Denmark
-
Gelesis, Inc.CompletedStudy of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 DiabetesObesity | OverweightUnited States, Canada, Czechia, Denmark, Italy, Spain
-
University Hospital TuebingenGerman Research FoundationCompletedAnemia of PrematurityGermany, Denmark
-
Novo Nordisk A/SRecruitingObesityBelgium, United Kingdom, United States, Sweden, Portugal, Austria, Germany, Israel, Mexico, Denmark
-
Novo Nordisk A/SCompletedObesity | OverweightGermany, Denmark, Canada, United States, Russian Federation, Finland, Poland, France, Japan
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, United Kingdom, Canada, Denmark, Finland, Serbia, Poland, Japan, South Africa, Ireland
-
Novo Nordisk A/SRecruitingObesity | OverweightBrazil, United States, Argentina, Australia, Canada, Denmark, Germany, Greece, Italy, Japan, Latvia, Malaysia, Netherlands, Norway, South Africa, Sweden, Taiwan, Thailand, United Kingdom, Algeria, Croatia, Finland, India, Ireland
-
Novo Nordisk A/SCompletedObesityUnited Kingdom, Canada, Denmark, Finland, Spain
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, Israel, Spain, Netherlands, Sweden, Switzerland, South Africa, Denmark, Portugal, Ukraine
-
Gelesis, Inc.UnknownObesity | Diabetes | Overweight | PreDiabetesUnited States, United Kingdom, Poland, Hungary, Italy, Canada, Czechia, Denmark
-
Novo Nordisk A/SActive, not recruitingObesityFinland, Spain, Taiwan, Korea, Republic of, United States, Netherlands, India, Japan, United Kingdom, Germany, Serbia, Denmark, Canada, Bulgaria, Australia, South Africa, Italy, Poland, Mexico, Belgium, Turkey, France, Argentina
-
Helsingborgs HospitalLund University; Region Skåne - Skånevård SUND; Copenhagen Trial Unit, Center... and other collaboratorsCompletedOut-of-hospital Cardiac ArrestNorway, Sweden, Denmark, France, New Zealand, United Kingdom, Belgium, United States, Australia, Austria, Czechia, Germany, Italy, Switzerland
-
Novo Nordisk A/SCompletedOverweight or Obesity | Metabolism and Nutrition DisorderUnited States, India, Mexico, Russian Federation, United Kingdom, Canada, Denmark, Finland, Belgium, Japan, Taiwan, France, Poland, Germany, Bulgaria, Argentina, Puerto Rico
-
Novo Nordisk A/SCompletedObesityUnited States, Spain, Australia, Hungary, United Kingdom, Netherlands, Canada, Argentina, Czechia, Germany, Denmark, Israel, Poland
-
Novo Nordisk A/SCompletedObesitySpain, United States, France, Russian Federation, Canada, Colombia, South Africa, Norway, Denmark, Saudi Arabia, Sweden
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
-
Novo Nordisk A/SRecruitingCardiovascular DiseaseNetherlands, Australia, Italy, United States, Serbia, Malaysia, Spain, United Kingdom, Thailand, India, Turkey, Mexico, Canada, Bulgaria, Argentina, Germany, France, Poland, South Africa, Brazil, Colombia, Denmark, Ireland, Japan
-
Boehringer IngelheimRecruitingObesityUnited States, Korea, Republic of, Belgium, Australia, United Kingdom, Mexico, Spain, Germany, Taiwan, Netherlands, Brazil, Hungary, Denmark, Canada, Poland, Austria, China, Finland, Greece, Italy, Hong Kong, Czechia, Portugal, Saudi... and more
-
Eli Lilly and CompanyRecruitingObesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | T2DUnited States, Mexico, Canada, Austria, Netherlands, Denmark
-
Boehringer IngelheimRecruitingObesity | Diabetes Mellitus, Type 2United States, Korea, Republic of, Belgium, Spain, China, Australia, Hungary, Canada, Czechia, Poland, New Zealand, Denmark, Finland, Germany, Greece, Netherlands, Sweden, Japan, United Kingdom
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, Poland, Israel, Italy, Mexico, Spain, Canada, Denmark, Finland, United Kingdom, France, Netherlands, Austria, Belgium, Argentina, Russian Federation, Serbia, Turkey, Switzerland, Germany, South Africa, Hungary, Hong Kong and more
-
Eli Lilly and CompanyRecruitingOverweight and ObesityUnited States, Australia, Italy, Hungary, Spain, Canada, Germany, Argentina, Belgium, Czechia, Greece, Israel, Austria, Brazil, Mexico, Netherlands, Romania, India, United Kingdom, Slovakia, Poland, Turkey, Puerto Rico, France, Denmark